AQP5-AS1 and kidney cancer: This study found and confirmed for the first time that MIAC directly binds to AQP2 inhibiting the expression of EREG, EGFR and the activation of downstream PI3K/AKT and mTOR signaling pathways to achieve the inhibitory effect of kidney cancer growth and metastasis (Fig. 7).